Protective effects of calcitonin on IL-1 stimulated chondrocytes by regulating MMPs/TIMP-1 ratio via suppression of p50-NF-κB pathway

References

• Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–2126.
   PubMed Web of Science ®Google Scholar
• Blaney Davidson EN, van Caam AP. and van der Kraan PM, Osteoarthritis year in review 2016: biology. Osteoarthritis Cartilage. 2017;25:175–180.
   PubMed Web of Science ®Google Scholar
• Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in China: results from the China health and retirement longitudinal study. Arthritis Rheumatol. 2016;68:648–653.
   PubMed Web of Science ®Google Scholar
• Miller RE, Block JA, Malfait AM. What is new in pain modification in osteoarthritis? Rheumatology. 2018;57:99–107.
   Web of Science ®Google Scholar
• Nelson AE. Osteoarthritis year in review 2017: clinical. Osteoarthritis Cartilage. 2018;26:319–325.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Wildi LM, Pelletier JP. Future therapeutics for osteoarthritis. Bone. 2012;51:297–311.
   PubMed Web of Science ®Google Scholar
• Wieland HA, Michaelis M, Kirschbaum BJ, et al. Osteoarthritis - an untreatable disease? Nat Rev Drug Discov. 2005;4:331–344.
   PubMed Web of Science ®Google Scholar
• DiDomenico CD, Lintz M, Bonassar LJ. Molecular transport in articular cartilage - what have we learned from the past 50 years? Nat Rev Rheumatol. 2018.
   PubMed Web of Science ®Google Scholar
• Troeberg L, Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta. 2012;1824:133–145.
   PubMed Web of Science ®Google Scholar
• Li NG, Tang YP, Duan JA, et al. Matrix metalloproteinase inhibitors: a patent review (2011–2013). Expert Opin Ther Pat. 2014;24:1039–1052.
   PubMed Web of Science ®Google Scholar
• Xie XW, Wan RZ, Liu ZP. Recent research advances in selective matrix metalloproteinase-13 inhibitors as anti-osteoarthritis agents. ChemMedChem. 2017;12:1157–1168.
   PubMed Web of Science ®Google Scholar
• Winum JY, Scozzafava A, Montero JL, et al. The sulfamide motif in the design of enzyme inhibitors. Expert Opin Ther Pat. 2006;16:27–47.
   PubMed Web of Science ®Google Scholar
• Dzwonek J, Rylski M, Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 2004;567:129–135.
   PubMed Web of Science ®Google Scholar
• Houard X, Goldring MB, Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep. 2013;15:375.
   PubMed Web of Science ®Google Scholar
• Chesnut CH, Azria M, Silverman S, et al. Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int. 2008;19:479–491.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Sondergaard BC, Arnold M, et al. Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann N Y Acad Sci. 2007;1117:181–195.
   PubMed Web of Science ®Google Scholar
• Sondergaard BC, Wulf H, Henriksen K, et al. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthr Cartil. 2006;14:759–768.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Tanko LB, Riis BJ, et al. Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA? Osteoarthritis Cartilage. 2006;14:617–624.
   PubMed Web of Science ®Google Scholar
• Little CB, Barai A, Burkhardt D, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 2009;60:3723–3733.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu T, Xu B, et al. Oxytocin prevents cartilage matrix destruction via regulating matrix metalloproteinases. Biochem Biophys Res Commun. 2017;486:601–606.
   PubMed Web of Science ®Google Scholar
• Liang Y, Duan L, Xiong J, et al. E2 regulates MMP-13 via targeting miR-140 in IL-1β-induced extracellular matrix degradation in human chondrocytes. Arthritis Res Ther. 2016;18:105.
   PubMed Web of Science ®Google Scholar
• Liu J, Cao L, Gao X, et al. Ghrelin prevents articular cartilage matrix destruction in human chondrocytes. Biomed Pharmacother. 2018;98:651–655.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Squires GR, Mousa A, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005;52:128–135.
   PubMed Web of Science ®Google Scholar
• Sondergaard BC, Madsen SH, Segovia-Silvestre T, et al. Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes. BMC Musculoskelet Disord. 2010;11:62.
   PubMed Web of Science ®Google Scholar
• Saklatvala J. Inflammatory signaling in cartilage: MAPK and NF kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr Drug Targets. 2007;8:305–313.
   PubMed Web of Science ®Google Scholar
• Ji B, Guo W, Ma H, et al. Isoliquiritigenin suppresses IL-1β induced apoptosis and inflammation in chondrocyte-like ATDC5 cells by inhibiting NF-κB and exerts chondroprotective effects on a mouse model of anterior cruciate ligament transection. Int J Mol Med. 2017;40:1709–1718.
   PubMed Web of Science ®Google Scholar
• Luo M, Hu L, Li D, et al. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1 beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line. Mol Immunol. 2017;90:1–10.
   PubMed Web of Science ®Google Scholar
• Gu H, Jiao Y, Yu X, et al. Resveratrol inhibits the IL-1β-induced expression of MMP-13 and IL-6 in human articular chondrocytes via TLR4/MyD88-dependent and -independent signaling cascades. Int J Mol Med. 2017;39:734–740.
   PubMed Web of Science ®Google Scholar
• Kim SR, Jung YR, An HJ, et al. Anti-wrinkle and anti-inflammatory effects of active garlic components and the inhibition of MMPs via NF-κB signaling. PLoS One. 2013;8:e73877.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ming J, Li Y, et al. Surfactant protein D attenuates nitric oxide-stimulated apoptosis in rat chondrocyte by suppressing p38 MAPK signaling. Biochem Biophys Res Commun. 2018;495:526–532.
   PubMed Web of Science ®Google Scholar